News

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.
Recent research confirms that aluminum in childhood vaccines does not increase the risk of autoimmune, allergic or ...
For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...
For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study published online July 15 in the American Journal of Clinical Dermatology. Andrew ...
Any vitamin D treatment in pregnancy may help prevent childhood asthma (1 study, 236 participants), and higher-dose vitamin D treatment in pregnancy likely helps prevent childhood wheeze (3 studies, ...
Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.
Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.
Apogee plans to conduct Phase 2b trials in asthma and eosinophilic esophagitis (EoE) with trial designs informed by APEX Part B dose optimization as well as the Phase 1b results in asthma. Apogee ...
Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis ...
When your lips are on the sensitive side, not every pretty shade is worth the risk. But for some shoppers, the search ended the moment they swiped on Kiko Milano’s Jelly Stylo in shade 505 — a glossy, ...
Get insights on Corvus Pharmaceuticals' Q2 2025 earnings call. Learn about soquelitinib's clinical progress, Phase II trial plans, and financial strategies.
Minghui Pharmaceutical Ltd. announced it is raising $131 million in a pre-IPO financing round Aug. 7. The funds will be used to advance its cancer and inflammatory disease pipeline, which include a PD ...